Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsGold Coast Boniva IV Coverage Policy | OpenPayer
    Ask Trek AI about this page
    CurrentGold Coast Health PlanPolicy N/A

    Boniva IV (ibandronate sodium) Coverage Criteria

    Customize your policy alerts

    Sign up for all goldcoasthealthplan policy alerts

    Know when goldcoasthealthplan releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs prior authorization and Part B coverage of Boniva IV for osteoporosis in postmenopausal women. Supporting medical records and compliance with LCD L34648 are required.

    Policy Summary
    PayerGold Coast Health Plan
    PolicyBoniva IV (ibandronate sodium) Coverage Criteria
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateAug 21, 2025
    Last ReviewAug 21, 2025
    Next Review DateN/A
    Key ActionSubmit medical records and follow LCD L34648 when requesting prior authorization for Boniva IV.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Postmenopausal osteoporosisCovered indication
    2 yearsCoverage duration
    J1740Billing code
    1 mgBilling unit
    Records required

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Documentation

    Boniva IV Coverage Criteria

    Initial Boniva IV coverage

    Covered when all applicable requirements are met.

    Boniva IV coverage requirements

    • The patient has osteoporosis and is a postmenopausal woman.
    • Medical records supporting the request are submitted.
    • Therapy follows LCD L34648, Bisphosphonate Drug Therapy.
    • Dosing is consistent with FDA-approved labeling or accepted standards of medical practice.

    Initial Boniva IV Therapy

    Initial Boniva IV therapy

    Boniva IV is covered for the treatment of osteoporosis in postmenopausal women when required documentation and LCD requirements are met.

    Initial therapy requirements

    • The patient is a postmenopausal woman with osteoporosis.
    • Supporting medical records are provided.
    • LCD L34648, Bisphosphonate Drug Therapy, requirements are followed.
    • The dose is consistent with FDA-approved labeling or accepted standards of medical practice.

    Boniva IV Billing Code

    Boniva IV billing codeHCPCSCovered
    J1740Boniva IV (ibandronate sodium)

    Prior Authorization and Documentation

    Prior Authorization

    Boniva IV prior authorization

    Prior authorization is required for Boniva IV. The request must be supported by medical records and must follow LCD L34648 for bisphosphonate drug therapy.

    Documentation Required

    Required medical records

    Medical records supporting the Boniva IV request must be provided.

    Denial Risk

    Missing supporting medical records

    Boniva IV Policy Background

    Boniva IV (ibandronate sodium) is a bisphosphonate indicated for the treatment of osteoporosis in postmenopausal women. This policy applies to Part B coverage for the FDA-approved indication when supporting medical records are provided, LCD L34648 requirements are followed, and dosing is consistent with FDA-approved labeling or accepted standards of medical practice. Coverage is available for up to two years.

    Policy Summary
    PayerGold Coast Health Plan
    PolicyBoniva IV (ibandronate sodium) Coverage Criteria
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateAug 21, 2025
    Last ReviewAug 21, 2025
    Next Review DateN/A
    Key ActionSubmit medical records and follow LCD L34648 when requesting prior authorization for Boniva IV.
    SourceLink
    On This Page
    Boniva IV Coverage CriteriaInitial Boniva IV TherapyBoniva IV Billing CodePrior Authorization and DocumentationBoniva IV Policy Background

    A request may be denied if medical records supporting the Boniva IV request are not provided.

    Denial Risk

    Failure to follow LCD L34648

    Coverage must comply with LCD L34648, Bisphosphonate Drug Therapy.